NASDAQ:CHRS | EBITDA | Coherus Oncology, Inc.

Complete source-backed ebitda history.

Available history
2012-12-31 to 2025-12-31
Data captured

Historical EBITDA

DateEBITDA
2025-12-31-$45.58M
2025-09-30-$44.03M
2025-06-30-$45.19M
2025-03-31-$45.04M
2024-12-31-$45.28M
2024-09-30-$46.46M
2024-06-30-$39.13M
2024-03-31-$67.19M
2023-12-31-$68.21M
2023-09-30-$31.21M
2023-06-30-$33.74M
2023-03-31-$66.85M
2022-12-31-$50.49M
2022-09-30-$79.55M
2022-06-30-$43.11M
2015-06-30-$58.5M
2015-03-31-$36.52M
2014-12-31-$26.33M
2014-09-30-$6.23M
2014-06-30-$17.81M
2014-03-31-$13.65M
2013-12-31-$10.38M
2013-09-30-$6.68M

Annual EBITDA

DateEBITDA
2025-12-31-$179.83M
2024-12-31-$198.05M
2023-12-31-$200M
2022-12-31-$253.28M
2021-12-31-$260.36M
2014-12-31-$64.01M
2013-12-31-$35.59M
2012-12-31-$38.3M